- Home
- Publications
- Publication Search
- Publication Details
Title
Safinamide for the treatment of Parkinson’s disease
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 7, Issue 6, Pages 747-759
Publisher
Informa UK Limited
Online
2014-10-10
DOI
10.1586/17512433.2014.968555
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis
- (2013) Damineh Morsali et al. BRAIN
- Pharmacokinetic Considerations for the Use of Levodopa in the Treatment of Parkinson Disease
- (2013) Thomas Müller CLINICAL NEUROPHARMACOLOGY
- Pramipexole Reduces Phosphorylation of α-Synuclein at Serine-129
- (2013) Kai-Yin Chau et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
- (2013) Anthony HV Schapira et al. LANCET NEUROLOGY
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys
- (2013) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Disposition and Metabolism of Safinamide, a Novel Drug for Parkinson's Disease, in Healthy Male Volunteers
- (2013) Chiara Leuratti et al. PHARMACOLOGY
- Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects
- (2012) Sonja Krösser et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- A Systematic Review of Catechol-O-Methyltransferase Inhibitors
- (2012) Sandro Zambito Marsala et al. CLINICAL NEUROPHARMACOLOGY
- Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease
- (2012) A. H. V. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Indirect Comparisons of Adverse Events and Dropout Rates in Early Parkinson's Disease Trials of Pramipexole, Ropinirole, and Rasagiline
- (2012) Francisco J. Zagmutt et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- l-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells
- (2012) Branden J. Stansley et al. NEUROPHARMACOLOGY
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
- (2011) Susan Duty et al. BRITISH JOURNAL OF PHARMACOLOGY
- Medical Management of Parkinsons Disease: Focus on Neuroprotection
- (2011) Camilo Rios et al. Current Neuropharmacology
- Motor Complications in Parkinson's Disease
- (2011) William G. Ondo INTERNATIONAL JOURNAL OF NEUROSCIENCE
- A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients
- (2011) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists
- (2011) Vibeke Guldbrand Rasmussen et al. MOVEMENT DISORDERS
- Does levodopa accelerate the pathologic process in Parkinson disease brain?
- (2011) L. Parkkinen et al. NEUROLOGY
- Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
- (2011) Hideyuki Sawada et al. PLoS One
- Insights into the Sigma-1 receptor Chaperone's cellular functions: A microarray report
- (2011) Shang-Yi Tsai et al. SYNAPSE
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
- (2010) Walter J. Schulz-Schaeffer ACTA NEUROPATHOLOGICA
- Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study
- (2010) Fabrizio Stocchi et al. ANNALS OF NEUROLOGY
- Safinamide in the treatment of Parkinson's disease
- (2010) Anthony HV Schapira EXPERT OPINION ON PHARMACOTHERAPY
- Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
- (2010) Paolo Calabresi et al. LANCET NEUROLOGY
- Missing pieces in the Parkinson's disease puzzle
- (2010) Jose A Obeso et al. NATURE MEDICINE
- Optimizing Long-Term Therapy for Parkinson Disease
- (2009) Mark Stacy et al. CLINICAL NEUROPHARMACOLOGY
- Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled Trial
- (2009) Frances M. Weaver JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Medical Treatment of Parkinson Disease
- (2009) Mark Stacy NEUROLOGIC CLINICS
- Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease
- (2009) A. H.V. Schapira NEUROLOGY
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease
- (2009) Carl E. Clarke et al. PARKINSONISM & RELATED DISORDERS
- Treatment of levodopa-induced motor complications
- (2008) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started